Ticker Details
Keros Therapeutics, Inc.
IPO Date:	April 8, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$221.47M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.11 | 2.63%
Avg Daily Range (30 D):	$0.28 | 2.44%
Avg Daily Range (90 D):	$0.29 | 2.15%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.27M
Avg Daily Volume (90 D):	.3M

Trade Size
Avg Trade Size (Sh.):	60
Avg Trade Size (Sh.) (30 D):	47
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	2,134
Avg Institutional Trade:	$1.88M
Avg Institutional Trade (30 D):	$.69M
Avg Institutional Trade (90 D):	$1.03M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.9M
Avg Closing Trade (30 D):	$.69M
Avg Closing Trade (90 D):	$1M
Avg Closing Volume:	61.02K

News

Mar 9, 2026 @ 12:00 PM Keros Therapeutics Presents Additional Clinical Da... Source: Na

Nov 20, 2025 @ 9:01 PM Keros Therapeutics Announces Final Results of Tend... Source: Globe Newswire

Nov 19, 2025 @ 11:00 AM Keros Therapeutics Announces Preliminary Results o... Source: Keros Therapeutics, Inc.

Sep 23, 2025 @ 5:00 PM TGF-β Inhibitors Clinical Trial Pipeline Accele... Source: Delveinsight

May 27, 2025 @ 5:45 PM Leading Independent Proxy Advisory Firm Glass Lewi... Source: Keros Therapeutics, Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.53	$-1.21	$-.38
Diluted EPS	$-2.53	$-1.21	$-.38
Revenue	$32.7M	$.03M	$.38M
Gross Profit
Net Income / Loss	$-85.15M	$-23.71M	$-23.46M
Operating Income / Loss	$-110.35M	$-25.88M	$-29.27M
Cost of Revenue
Net Cash Flow	$-439.04M	$-5.92M	$-406.06M
PE Ratio